Advanced Hands-on Thyroid Ultrasound Workshop 2018

Chicago, IL US

Click "Start" to evaluate sessions, claim CME & Maintenance of Certification (MOC) points, and print a certificate of attendance or certificate of participation

In order to earn and report MOC points to the American Board of Internal Medicine (ABIM), you must:

  1. Provide your board-certification information in your educational profile
  2. Evaluate the MOC sessions you attended through this form

Review Profile

Target Audience

This program should be of substantial interest to endocrinologists and other healthcare providers involved in the management of thyroid-related disorders.

Learning Objectives

Upon completion of this educational activity, learners will be able to:

  • Review indications for an ultrasound examination of cervical lymph nodes in thyroid cancer patients
  • Demonstrate the imaging procedure and identify characteristics of benign and malignant lymph nodes
  • Discuss and illustrate the imaging characteristics of parathyroid adenomas
  • Practice specimen slide preparation and cytology interpretation

Additional Information

Target Audience: 
Clinical researcher
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Interpersonal and Communication Skills
Topic Area: 
Thyroid/HPT Axis
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Level 4 (Learning: Competence (Shows How))
Activity summary
Available credit: 
  • 8.75 ABIM MOC
  • 8.75 AMA PRA Category 1 Credits
  • 8.75 CME Certificate of Participation
Course opens: 
Course expires: 
McCormick Place West
2301 S Prairie Ave
Chicago, IL 60616
United States

Course Directors

Jennifer A Sipos, MD; Ohio State Univ
Stephanie L. Lee, MD; PhD, Boston Med Ctr

Robert Levine, MD; Thyroid Ctr of New Hampshire
Jennifer A Sipos, MD; Ohio State Univ
Kevin T. Brumund, MD; Univ of California San Diego Moores Cancer Ctr
Susan J. Mandel, MD; MPH, Univ of Pennsylvania, Perelman Sch of Med
Cord Sturgeon, MD; Northwestern Univ Feinberg Sch of Med
Stephanie L. Lee, MD; PhD, Boston Med Ctr
Denise M. Carneiro‐Pla, MD; Med Univ of South Carolina
Poorani Goundan, MD; Boston Med Ctr
Mark A. Lupo, MD; Thyroid & Endocrine Ctr of Florida

Hands-on Preceptors
Tracy Tylee, MD; Univ of Washington
Eve Bloomgarden, MD; Northwester Univ
Kevin T. Brumund, MD, Univ of California San Diego Moores Cancer Ctr
Trevor Angell, MD; Brigham and Women's Hospital
Poorani Goundan, MD; Boston Med Ctr
Giuseppe Barbesino, MD, Massachusetts Gen Hosp
Nicole A. Massoll, MD, Univ of Arkansas for Med Sch

Special thanks to Ellie (Hawkinson) O'Brien and the Center for Education in Medicine at Northwestern University's Feinberg School of Medicine for the development of the neck/thyroid models used in the practicum session. For more information, visit


The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Robert Levine, MD; Jennifer A. Sipos, MD; Kevin T. Brumund, MD; Susan J. Mandel, MD, MPH;  Cord Sturgeon, MD; Stephanie L. Lee, MD, PhD; Denise M. Carneiro‐Pla, MD; Poorani Goundan, MD; Mark A. Lupo, MD;  Tracy Tylee, MD; Eve Bloomgarden, MD; Trevor Angell, MD; Giuseppe Barbesino, MD; Nicole A. Massoll, MD

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

DISCLAIMERS USE OF PROFESSIONAL JUDGMENT: The educational content in this activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.

DRUGS AND DOSAGES: When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

POLICY ON UNLABELED/OFF-LABEL USE The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

PRIVACY AND CONFIDENTIALITY STATEMENT The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT This educational activity is supported by an independent medical educational grant from Esaote North America, FNApath, RGS Healthcare.

Accreditation Statement

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this enduring material for a maximum of 8.75AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Available Credit

  • 8.75 ABIM MOC
  • 8.75 AMA PRA Category 1 Credits
  • 8.75 CME Certificate of Participation